Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 85 (2), 214-224
- https://doi.org/10.1038/labinvest.3700214
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- How Are Alkynes Scrambled?Science, 2005
- Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancersOncogene, 2004
- Cell-Type-Specific Repression of the Maspin Gene Is Disrupted Frequently by Demethylation at the Promoter Region in Gastric Intestinal Metaplasia and Cancer CellsThe American Journal of Pathology, 2003
- Mutant p53 and aberrant cytosine methylation cooperate to silence gene expressionOncogene, 2003
- p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancerJournal of Surgical Oncology, 2003
- Expression of maspin predicts poor prognosis in breast‐cancer patientsInternational Journal of Cancer, 2002
- Role for DNA methylation in the control of cell type–specific maspin expressionNature Genetics, 2002
- Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breastThe Journal of Pathology, 2001
- High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinomaOncogene, 2000
- X inactivation, differentiation, and DNA methylationCytogenetic and Genome Research, 1975